Fontolizumab

Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gamma antibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease[1].

Product Specifications

CAS Number

[326859-36-3]

Product Name Alternative

HuZAF; Anti-Human IFNG Recombinant Antibody

UNSPSC

12352203

Target

IFNAR

Type

Inhibitory Antibodies

Related Pathways

Immunology/Inflammation

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/fontolizumab.html

Purity

97.18

Solubility

10 mM in DMSO

Smiles

[Fontolizumab]

Molecular Weight

(144.8 kDa)

References & Citations

[1]Hommes DW, et, al. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut. 2006 Aug;55 (8) :1131-7.